Max International ANNOUNCES Its Unique and Unparalleled Medical Advisory Board

8/3/2019 Max International ANNOUNCES Its Unique and Unparalleled Medical Advisory Board

http://slidepdf.com/reader/full/max-international-announces-its-unique-and-unparalleled-medical-advisory-board 1/11

Max International ANNOUNCES itsUnique and Unparalleled Medical Advisory Board

While most pharmaceutical and nutriceutical

companies have medical advisory boards, to our knowledge, NONE have one like that of Max

International. The uniqueness of Max's medical advisory board begins with the diversity of itsmembers. It is rare that such a board is made up of members representing such diverse

medical and scientific disciplines. For example the board includes the current dean of a

college of pharmaceutical sciences at a renowned university, a world renowned

pathologist, a heart surgeon, and orthopedic surgeon, two ob/gyns, an immunologist, a

pediatrician, medical school professors and other premier medical professionals.

Even more astonishing, Max's medical advisory board members receive no financial

compensation for being on our board. The doctors, scientists and educators on our advisory

board are participating for one reason²they believe in our science and the extraordinary

breakthrough products that have been and will be developed by our science. It is also

important to note that each member of this board uses Max products in their quest for optimal

health.

As you will see, their achievements and credentials within their respective medical fields are

stellar. Their participation on our board is something every Max Associate should be proud

of and utilize as they share the Max vision and products with others. Their unpaid participation

in our board brings a level of credibility to our science and products that is truly unparalleled in

the nutritional world.



Max's Medical Advisory Board

Jeanette C. Roberts, Ph.D. Medicinal Chemistry

Dean, School of Pharmacy, The University of Wisconsin

Professor, Pharmaceutical Sciences, University of Wisconsin

Dr. Roberts received her Ph.D in Pharmaceutical Chemistry from theUniversity of Minnesota in 1986. Dr. Roberts has authored more than 50 peer-reviewed articles in various scientific journals. She has served in numerousfaculty positions at both the University of Wisconsin and the University of Utah. In addition to her duties as Dean of the School of Pharmacy at theUniversity of Wisconsin, she is also an adjunct professor of Pharmacology andToxicology and an Adjunct Professor of Medicinal Chemistry for theUniversity of Utah. She has been the recipient of more than one milliondollars in study grants from various scientific bodies including NASA, theCancer Research Foundation of America, and the Armed Forces RadiobiologyResearch Institute. She has also been awarded numerous patents and a myriadof academic and scientific awards. She has witnessed first hand theextraordinary benefits of Max International's RiboCeine, as she participatedin fifteen published studies on RiboCeine conducted over a period of nineteen years (from 1985 and 2004).

Douglas S. Harrington M.D., Pathology and Hematology,FASCP, FCAP

Clinical Associate Professor of Pathology, University of Southern

California, Keck School of Medicine.

Dr. Harrington currently serves as CEO of Aviir, Inc, a Stanford Universityspin-out cardiac biomarker company. He holds multiple professionalaffiliation memberships including the American Medical Association, theAmerican Society of Clinical Pathologists, the College of American

Pathologists, the Association for Molecular Pathology and the InternationalAcademy of Pathology. Dr. Harrington received his B.A. in Molecular Biology and M.D. from the University of Colorado. He is Board Certified inAnatomic and Clinical Pathology and Hematology and has authored numerous peer-reviewed publications. He is licensed in a number of states including New York where he holds CQ's in Molecular and Biochemical Genetics. Dr.Harrington has taken a number of new molecular technologies (both servicesand devices) through state and federal regulatory approval. He has multiple



professional affiliations including the American Medical Association and TheAssociation for Molecular Pathology, and has authored over 80 scientificstudies and publications. Dr. Harrington has more than twenty-five years oexperience in the commercialization of healthcare technologies. Most recentlyhe has created a breakthrough methodology for the accurate prediction of

heart attacks and strokes, even among population groups formerly consideredto be of no risk to low risk for such events. His company has receivedextraordinary acclaim and funding from the National Institutes of Health and pharmaceutical companies to advance his program throughout the medicalworld as quickly as possible. During the past several years, Dr. Harringtonwitnessed the transformational impact of elevated glutathione levels fromMax's products in his own life and the lives of his immediate and extendedfamily members. He now promotes and clinically recommends the use of Max products to everyone who wants to maximize their health and quality of life.

Greg Brevitti, M.D. Cardiovascular Surgeon, FACS., FACC., FACCP.

Assistant Professor of Surgery (Cardiothoracic), The State University of

New York- Health Sciences Center at Brooklyn.

Dr. Brevitti received his M.D. degree from The State University of New York Health Sciences Center at Brooklyn, College of Medicine in 1993. He is athird generation physician after his father and grandfather. He pursuedspecialization in surgery at The University of Iowa Hospitals and Clinics from1993 through 1998 and Cardiothoracic Surgery at The University of California-San Francisco from 1998 through 2000. He is a Fellow of theAmerican College of Surgeons, The American College of Cardiology, The

American College of Chest Physicians, and a member of the Society of Thoracic Surgeons. Dr. Brevitti is the founder of a large surgicalmultispecialty group in New York City and the author of numerous peer-reviewed scientific articles. Several years ago, Dr. Brevetti reviewed all of the published scientific data on Riboceine and numerous scientific articles onglutathione and disease processes and its role as an antioxidant. He came awaywith a clear understanding that organized medicine had generally neglectedthis very important molecule. He became a user of the Max's products both personally and professionally and has been an articulate advocate for Max'sRiboCeine powered products ever since.



Rex Anderson Jr. M.D., Neurology

Founder, NeuroMedical Institute for Age Management

Dr. Rex Anderson, Jr. M.D received his medical degree from the University of

Texas Medical Branch in Galveston, Texas. After a mixed medicineinternship, he completed a residency program in neurology at the Universityof Utah College of Medicine in Salt Lake City, Utah. Afterward, he spent twoyears in the armed forces and then established a neurology practice.Throughout his 30 years of neurological practice Dr. Anderson witnessed alarge variety of acute neurological and chronic degenerative diseases. Herealized the best treatment was prevention. Taking a proactive approach, hefounded the NeuroMedical Institute for Age Management in Dallas, focusingon preventing degenerative diseases before they occur. He completedPhysician Training & Certification in Age Management Medicine, jointlysponsored by Cenegenics Education and Research Foundation (CERF) and theFoundation for Care Management (FCM). Dr. Anderson became a

Cenegenics® Medical Institute physician affiliate because of their extensiveexperience in age management medicine, evidence-based approachs,continued education emphasis as well as their strong insistence on medicalexcellence and quality patient care. In 2008, he partnered with Cenegenics andDr. Paul D. Thompson to establish a progressive-edge medical center,Cenegenics Dallas-Ft. Worth. With more than three decades of neurological practice, Dr. Anderson has a particular interest in helping patients maintain the best possible brain function. After studying the science surroundingglutathione enhancement and experiencing the benefits of Max products firsthand, Dr. Anderson began recommending Max to his clients. The results hesaw were so profound, he decided to require all new clients to begin usingMax as a part of their age-management program.

Don Colbert M.D., Family Practice and Integrative

Medicine

NY Times Best Selling Author and Medical Director, Divine Health and

Wellness Center

Don Colbert, M.D. is board certified in family practice and integrativemedicine. He is the Medical Director of the Divine Health Wellness Center inOrlando, Florida as well as the Medical Director of Harvest TimeInternational. He is an internationally known expert and prolific speaker onintegrative medicine. Dr. Colbert is on the Medical Advisory Board for theFellowship of Christian Athletes. Dr. Colbert has been featured on Fox News,ABC World News, The Atlanta Journal Constitution, BBC, Readers Digest, News Week, Prevention Magazine, Joyce Meyer, Kenneth Copeland'sBelievers Voice of Victory, This is Your Day, John Hagee and many others.He is a best-selling author of over 40 books (ten million copies) including The

Seven Pillars of Health, Toxic Relief, Deadly Emotions, and Stress Less as



well as the New York Times Best Selling books The Seven Pillars of Health and I Can Do This Diet . He is also the radio host of his syndicated program"Dr Colbert's Health Report." Dr. Colbert has long been a proponent of thecritical importance of glutathione enhancement and has used intravenousglutathione treatments with many of his patients. When he began using the

oral supplements, MaxGXL and MaxOne, he was shocked by their extraordinary performance. But he stated that Cellgevity has taken glutathioneenhancement and nutritional supplementation to a whole new level. In hislatest book, he wrote, "Cellgevity is the most powerful anti-aging, detoxifyingand anti-inflammatory supplement that I have ever experienced."

Dr. Rex Manayan M.D, Thoracic Surgeon

Dr. Manayan earned his medical degree from Tufts University, School of Medicine in Boston, MA in 1991. He completed his General Surgical Training

at Swedish Medical Center in Seattle, WA. Dr. Manayan completed aThoracic Surgery Fellowship at the Bristol Royal Infirmary, England. Prior tomedical school, Dr. Manayan received his Bachelor's and Master of ScienceDegrees in the Biological Sciences from the University of California, SanDiego. Dr. Manayan stated in an interview that with Thoracic Surgery often being a matter of life and death, during his long days of surgery, Max enabledhim to optimize his energy level and his focus like never before. As heexperienced the Max differences in his own life and the lives of his familymembers, he began offering it to his patients and saw the same kinds of results, almost universally.

Dr. Robert L. Reid, M.D., Orthopedic Surgeon F.R.C.S.(C)

Dr. Reid graduated from the University of Toronto Medical School in 1963,and completed his residency in Orthopedic Surgery in 1970, becoming aFellow of the Royal College of Physicians and Surgeons. He was Certified bythe American Board of Orthopedic Surgeons in 1972. He maintained a practice in Orthopedic Surgery from 1976 until he reached the Canadianmandatory retirement age for surgeons. His practice then changed to aspecialty in pain management, which continues to this day.



Dr. John Kindle M.D., Family Practice CCFP

Dr. John Kindle M.D. has been a family doctor in active practice for morethan 37 years. In the mid 1990's he was the Chief of Palliative Care at theRiverside Hospital in Ottawa Canada and that is when he was first exposed to

alternate treatments by his patients who introduced him to nutritionalsupplements to help their bodies heal. In 2003 Dr. Kindle became a survivor of kidney cancer and this further intensified his interest in prevention and therole of supplements in keeping the individual cells of our bodies healthy. Dr.Kindle began using Max products in 2007 and studied published scientificarticles on glutathione and glutathione enhancement. His commitment to MaxInternational continued to grow as he saw the extraordinary outcomes produced by the product in the lives of his clients.

Charles Mabry, M.D. OB/GYN

Dr. Charles Mabray is a graduate of Baylor College of Medicine and aDiplomat and Fellow at the American College of OB/GYN. He is a Diplomatof the American Board of Environmental Medicine and is certified with theAmerican Board of Bariatric Medicine. He has several publications in peer-reviewed journals and is the author of a book on nutrition and health, TheGenesis Strategy. Dr. Mabray considers himself to be a student of medicinewho isn't content to merely diagnose but is always asking how and why. Dr.Mabray said he constantly strives to establish better, less invasive, treatmentmethods that treat patients using few medications, while trying to raise patientawareness regarding personal responsibility. He is a long-time advocate of nutritional supplements. After his introduction to Max in May of 2007 he

began to offer MaxGXL on a small scale to patients, family and friends. "Itrapidly became obvious that MaxGXL had something special, yielding qualityof life improvement in multiple areas. I am now a full-fledged fan. I wouldencourage all of my medical friends to get acquainted with the Max line of products."

Dr. Raul Morales-Borges: Immunology, Hemotology,

Oncology, Angiology FICPS, FIACATH, FISH

Medical Director, American Red Cross, Blood Services of Puerto Rico

Dr. Raul H. Morales-Borges received his Bachelor Degree in Science with amajor in Pre Medical Sciences at the University of Puerto Rico in 1985, andMedical Doctor Degree at San Juan Bautista School of Medicine in Caguas,Puerto Rico in 1990. He completed his residency in Internal Medicine atHenry Ford Hospital in Detroit, Michigan in 1993 followed by his fellowshipin Hematology and Medical Oncology at Providence Hospital and Universityof Michigan Medical Center in Michigan in 1995.



He returned to Puerto Rico and has been working as a hematologist andmedical oncologist at a solo private practice at the Ashford Medical Center inSan Juan, Puerto Rico since the summer of 1995. Dr. Morales Borges is theMedical Director of the American Red Cross, Blood Services from Puerto

Rico since December of 2010. He is a former President of the AmericanCancer Society of Puerto Rico, former Trustee of the Ashford PresbyterianCommunity Hospital, and former Professor of Immunology, Genetics, andPathology and Chairman and Trustee of the Board of Trustees of San JuanBautista School of Medicine. Dr. Morales Borges is a Fellow of InteramericanCollege of Physicians and Surgeons (FICPS), Fellow of American Society of Angiology (FASA), Fellow of International Society of Hematology (FISH),and Fellow of International Academy of Clinical and Applied Thrombosis andHaemostasis (FIACATH). He is a speaker and member of the advisory boardof Sanofi Aventis. He is an active member of the American Association of Blood Banks and American Society for Apheresis.

Jack H. Tarr, M.D

Founder and President, Family Care Specialists, Knoxville, TN.

Dr. Jack Tarr has been a physician for 34 years and has been named by his peers as one of Knoxville's Top Doctors. He is the founding physician andPresident of a 10 provider medical group, Family Care Specialists, which seesover 70,000 patients a year. Dr. Tarr's areas of interest are treatment of varicose veins and difficult diagnostic challenges. Dr. Tarr is also thePresident and developer of Workforce Integrity Network, a national drug-

testing compliance company, and the President of DrugPak, one of the nation'sleading drug testing software companies. For over 38 years of marriage, Dr.Jack Tarr and his wife, Kathy, have worked together to forge a strong team inwhich they share their passions for family and medicine. Leveraging their combined gifts, they have raised six children and established a successfulmedical practice. Jack founded Family Care Specialists in 1986 after completing family practice residency, military service and seminary training.In addition to founding and developing a ten-provider medical practice, he hasconsistently brought leading edge concepts into his practice and community. Itis no surprise he now joins the growing number of physicians incorporatingMax products into their practice. He wrote, " Patients want a choice and I have

ound that most want a non-pharmaceutical approach if that will help them

with their quality of life issues. Max has changed my medical practice because I can finally recommend a nutritional supplement that truly impacts peopleand has real science behind it. Max products are the first and only

supplements in over 34 years that I have recommended to my patients and am glad to add them to my available options as a clinician. I have never seenany product, pharmaceutical or supplement, that do for the human body what

the Max Products do."

y Knoxville, TN Board Certified by The American Board of Family



Practice

y University of Tennessee Center for Health Sciences Medical Schooly Family Practice Residency at Naval Regional Medical Center in

Jacksonville, Florida

Dr. Dale J. Bradley, DO, Internal Medicine

Owner, Tyler Internal Medicine Associates, Tyler, Texas

Dr. Dale J. Bradley graduated from the Des Moines University, College Of Osteopathic Medicine and Surgery in 1994. He became a flight surgeon in theUnited States Air Force and attained the rank of Major. Following his time inthe Air Force, he began his private practice of Internal Medicine in Tyler,Texas. A longtime proponent of nutritional and cellular health, Dr. Bradley

was aware of the role of intercellular glutathione. When first introduced toMaxGXL, Dr. Bradley was skeptical that glutathione levels could be increased by an oral supplement. After a great deal of research, he and his wife decidedthey would try it. Within one week he and his wife experiencedtransformational results that he termed amazing. He then saw similar resultswith his extended family members. Extending its use to his patientstransformed the very nature of his practice.

Dr. Tim Kershenstein

Dr. Kershenstein specializes in tropical and integrative medicine. He hasstudied Eastern Medicine which focuses on the cause, not the symptoms, of adisease. " In my opinion the West is too quick to revert to pharmaceutical drugs for treatment when the use of a natural remedy would be more

appropriate and have fewer side effects." Dr. Kershenstein feels Max'sglutathione enhancing products are effective remedies. He said 80 percent of people he's presented Max products to have responded quickly with definitiveresults. His family and friends have improved their quality of life with dailyuse of these products. He said that he has given them to many of hiscolleagues and the results have been miraculous. Referring to his backgroundin a natural Eastern approach to healthcare, Dr. Kershenstein said that inChina doctors get paid when people are well instead of sick.



Gordon Crozier, D.O. OB/GYN

Division Director University of Kentucky, Morehead Women's Health

Dr. Crozier received his medical degree in 1994 from Des Moines University

and College of Osteopathic Medicine and Surgery. He completed hisresidency in Obstetrics and Gynecology in 1998 from Michigan StateUniversity, Garden City Hospital Campus. After ten years of private practice,he joined the faculty of the University of Kentucky Morehead, and in 2010was voted the school's top educator. He was also awarded a Fellowship, Anti-aging Functional and Regenerative Medicine, and is continuing his educationin nutritional and metabolic medicine at the University of South Florida. He isan outspoken advocate for Max's glutathione enhancing products and their role in anti-aging and enhanced wellness.

Max International, Research Team

Herbert T. Nagasawa, Ph.D., Executive Research

Scientist

Dr. Nagasawa received his B.S. degree in chemistry from Western ReserveUniversity (now, Case-Western Reserve) in Cleveland, Ohio, and a Ph.D.degree in organic chemistry from the University of Minnesota. Subsequently,he spent two years as a Post-doctoral Fellow in biochemistry at the University

of Minnesota before joining the research staff of the V.A. Medical Center inMinneapolis as a Senior Chemist. He was appointed Assistant Professor of Medicinal Chemistry at the University of Minnesota in 1959. He was namedPrincipal Scientist of the VAMC in 1961 and was promoted in 1976 to Senior Research Career Scientist, a nationwide VA title reserved for the VA's topscientists. He was promoted to Associate Professor in 1963 and to Professor of Medicinal Chemistry in 1973. He also held joint professorships in theDepartment of Pharmacology and the university-wide Division of Toxicology,and served as Visiting Professor at Washington State University in 1990. Healso served for 32 years as a Senior Editor for the prestigious internationalJournal of Medicinal Chemistry from 1972 to 2004, and one year as ActingEditor-in-Chief. In addition, he served on the Editorial Board of the journal,

Bioconjugate Chemistry for eight years, and as an ad hoc grant reviewer for the NCI and NIAAA, National Institutes of Health. He has published over 165 papers in peer-reviewed journals. In June of 2010, Herb attended the NationalInstitutes of Health-Homeland Security 4th Annual Countermeasures AgainstChemical Threats Network Symposium held in San Francisco. Herb and theteam of scientists presented their work on the cyanide antidote.



Dr. Scott Nagasawa, Pharm.D.

Scott Nagasawa received his Doctor of Pharmacy degree from the Universityof Southern California (USC) and is also a registered pharmacist. He spentover a dozen years at a 400-plus bed tertiary teaching hospital in Los Angeles,

California, affiliated with the University of Southern California. At the time of his departure, he was the Director of Pharmaceutical Services. During this period, he held the position of Clinical Instructor of Pharmacy Practice at USCand was later promoted to Adjunct Assistant Professor of Pharmacy Practice.

Scott transitioned to the business side of his profession and joined a regional pharmacy as their Vice President of Pharmacy Services. He was instrumentalin the planning and implementation of a strategic business plan transformingthe company from a regional to a nationwide pharmacy service provider withrevenues exceeding $60 million annually. At the time of his departure, he heldthe position of Senior Vice President of Professional Services responsible for nursing and pharmacy operations nationwide. He left to co-found a home

infusion pharmacy and helped develop and implement a business plan thatresulted in rapid growth to become a statewide provider. The company wassold in 2005. He remained with the company as V.P. of Operations and, at thetime of his departure, the monthly revenue had grown by roughly 40 times.This revenue growth occurred over his four and a half years with thecompany.

Scott, an original co-founder of CellGevity, then left to join Dr. Herb Nagasawa and Scott Momii at CellGevity, and served full-time as the Chief Technical Officer (CTO). As CTO he was responsible for product registration,company certifications, regulatory practices, safety studies, technical salessupport and the development and reviewing of product documentation.

Scott Momii, M.B.A. Executive Director of Product

Management

Scott Momii was co-founder of a prominent research, development andmanufacturing company for specialty chemicals. His managementresponsibilities included overseeing and implementation of sales andmarketing programs, domestic and international purchasing, as well ascustomer service and accounting. He spearheaded the development and launchof three products in the areas of cosmetics (which debuted in Japan), themotion picture film industry, and a proprietary coating for high-speed ball bearings used in medical applications. He was responsible for transferring themanufacturing of a proprietary chemical from the U.S. to India.Simultaneously, he served as Director of Operations of a sister companydeveloping biotechnology vaccines and cancer therapeutics, and specializingin pharmaceutical delivery systems based on liposomal technology. .

Early in his career, he helped start a software company that developed a



UNIX-based enterprise system designed for home infusion therapy andoutpatient pharmacies. He was responsible for the sales of the software to over 200 hospitals, pharmacies and five national companies. He engineered theeventual sale of the company to the largest nationwide software provider for home healthcare solutions.

Mr. Momii graduated with a B.A. degree from San Jose State University,received an M.B.A. from Boston University, and completed a summer business program at Sophia University, Tokyo, Japan.

Documents

Max International ANNOUNCES Its Unique and Unparalleled Medical Advisory Board